3252
T. Shinada et al. / Tetrahedron Letters 53 (2012) 3250–3253
aldehyde 5c to 2, which did not involve any oxidation-reduction
sequences, included six steps and the overall yield was 48% (38%
from (R)- -methylserine). The key to the total synthesis was the
Cu(t-butSal)2 (5 mol%)
NHBoc
CHO
5b R = TBS
5c R = MOM
O
Et3N (5 mol%)
+
RO
CN
a
N
DCE, rt
S
Cu(t-butSal)2-catalyzed isocyanoacetate aldol reaction of the alde-
hyde 5c with (1R)-11a to give (4R,5R)-16b (13:1) in which the
undesired (4S,5S)-isomer was the predominant product upon the
aldol reaction of the structurally rigid aldehyde 5a with an achiral
isocyanoacetate. The Oppolzer’s camphorsultam was proven to be
an excellent chiral auxiliary for the diastereoselective isocyanoac-
etate aldol reactions even for mismatched pair double asymmetric
induction. Current efforts are focused on further application of the
present method for the synthesis of highly functionalized natural
products having consecutive amino and hydroxy groups.
O2
= 13 : 1 (59%)
16a : 17a
16b : 17b
= 13 : 1 (84%)
(1R)-sultam 11a
NHBoc
O
NHBoc O
+
RO
RO
5
4
N
N
S
S
O2
O2
O
N
O
N
(4R,5R)-16a or 16b
(4S,5S)-17a or 17b
16a-19a R = TBS
16b-19b R = MOM
O2
Cu(t-butSal)2 (5 mol%)
Acknowledgments
S
N
NHBoc
CHO
Et3N (5 mol%)
CN
+
RO
This study was supported by Grants-in-Aid (Nos. 16201045,
16073214, 18510191, 19201045, and Innovative Areas ‘Chemical
Biology of Natural Products’) for Scientific Research from the Japan
Society for the Promotion of Science (JSPS) and the Ministry of Edu-
cation, Culture, Sports, Science, and Technology, Japan.
DCE, rt
O
= 1 : >20 (51%)
= 1 : >20 (72%)
5b R = TBS
5c R = MOM
18a : 19a
18b : 19b
(1S)-sultam 11b
NHBoc
O
NHBoc O
O2
S
O2
S
+
RO
RO
5
4
N
N
Supplementary data
O
N
O
N
Supplementary data associated with this article can be found, in
(4R,5R)-18a or 18b
(4S,5S)-19a or 19b
the
online
version,
at
Scheme 4. Aldol reactions of ring-opened aldehydes 5b,c with isocyanoacetate
bearing the chiral camphorsultam.
References and notes
1. (a) Scala, F.; Fattorusso, E.; Menna, M.; Taglialatela-Scafati, O.; Tierney, M.;
Kaiser, M.; Tasdemir, D. Mar. Drugs 2010, 8, 2162–2174; (b) Aiello, A.;
Fattorusso, E.; Menna, M.; Taglialatela-Scafati, O. In Modern Alkaloids;
Fattorusso, E., Taglialatela-Scafati, O., Eds.; Wiley-VCH, 2007; pp 271–304; (c)
Blunt, J. W.; Copp, B. R.; Hu, W.-P.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M.
R. Nat. Prod. Rep. 2008, 25, 35–94; (d) Endo, T.; Tsuda, M.; Okada, T.;
Mitsuhashi, S.; Shima, H.; Kikuchi, K.; Mikami, Y.; Fromont, J.; Kobayashi, J. J.
Nat. Prod. 2004, 67, 1262–1267; (e) Blunt, J. W.; Copp, B. R.; Munro, M. H. G.;
Northcote, P. T.; Prinsep, M. R. Nat. Prod. Rep. 2003, 20, 1–48; (f) Faulkner, D. J.
Nat. Prod. Rep. 2002, 19, 1–48; (g) Faulkner, D. J. Nat. Prod. Rep. 1998, 15, 113–
158.
O
H
5c
*
R
Et3N
C
L
Cu
H
O
O
(4R,5R)-16b
N
N
O
NHBoc
S
(1R)-11a
R* =
MOMO
O
H
*
R
2. Kobayashi, J.; Kanda, F.; Ishibashi, M.; Shigemori, H. J. Org. Chem. 1991, 56,
4574–4576.
3. Manzacidin D. The N-1 methylated debromo form of manzacidin A was isolated
from a fossil sponge, see: Jahn, T.; Konig, G. M.; Wright, A. D.; Worheide, G.;
Reitner, J. Tetrahedron Lett. 1997, 38, 3883–3884.
O
AcOH, THF, H2O
(3 : 1 : 1)
1. 6 N HCl
OHCHN
HO
2.
the same procedure
O
16a
16b
as those of 20 to 2
rt, 4 d
84%
4. For the total synthesis of manzacidins A and/or C: (a) Wehn, P. M.; Du Bois, J. J.
Am. Chem. Soc. 2002, 124, 12950–12951; (b) Lanter, J. C.; Chen, H.; Zhang, X.;
Sui, Z. Org. Lett. 2005, 7, 5905–5907; (c) Kano, T.; Hashimoto, T.; Maruoka, K. J.
Am. Chem. Soc. 2006, 128, 2174–2175; (d) Wang, Y.; Liu, X.; Deng, L. J. Am. Chem.
Soc. 2006, 128, 3928–3930; (e) Sibi, M. P.; Stanley, L. M.; Soeta, T. Org. Lett.
2007, 9, 1553–1556; (f) Wang, B.; Wu, F.; Wang, Y.; Liu, X.; Deng, L. J. Am. Chem.
Soc. 2007, 129, 768–769; (g) Tran, K.; Lombardi, P. J.; Leighton, J. L. Org. Lett.
2008, 10, 3165–3167; (h) Ichikawa, Y.; Okumura, K.; Matsuda, Y.; Hasegawa, T.;
Nakamura, M.; Fujimoto, A.; Masuda, T.; Nakano, K.; Kotsuki, H. Org. Biomol.
Chem. 2012, 10, 614–622; For the synthesis of manzacidin B: (i) Sankar, K.;
Rahman, H.; Das, P. P.; Bhimireddy, E.; Sridhar, B.; Mohapatra, D. K. Org. Lett.
2012, 14, 1082–1085; For the synthesis of manzacidin D: (j) Drouin, C.; Woo, J.
C. S.; MacKay, D. B.; Lavigne, R. M. A. Tetrahedron Lett. 2004, 45, 7197–7199; For
a review: (k) Hashimoto, T.; Maruoka, K. Org. Biomol. Chem. 2008, 6, 829–835.
5. (a) Namba, K.; Shinada, T.; Teramoto, T.; Ohfune, Y. J. Am. Chem. Soc. 2000, 122,
10708–10709; (b) Oe, K.; Shinada, T.; Ohfune, Y. Tetrahedron Lett. 2008, 49,
7426–7429.
NHBoc
Manzacidin B (2)
57% from 16b
4
1. 1 N LiOH
2. 6 N HCl
NH2 NH2
CO2H
HO
H
OH
20
Scheme 5. Proposed transition state model and conversion to manzacidin B.
model, approaches from the re-face of the Z-enolate of (1R)-11a
and the re-face of the aldehyde 5c would be the kinetically favored
process to give (4R,5R)-16b as the major diastereomer. The struc-
ture of 16a was unambiguously assigned to the (4R,5R,6R)-isomer
by converting it into the corresponding aminolactone 4 and its X-
ray crystallographic analysis (vide supra).22 Finally, the removal of
the camphorsultam group of the MOM-protected 16b under alka-
line hydrolysis followed by acidic treatment gave the amino acid
20, which, upon a three step conversion using our established
method,5 gave manzacidin B (2).23
6. (a) Shinada, T.; Ikebe, E.; Oe, K.; Namba, K.; Kawasaki, M.; Ohfune, Y. Org. Lett.
2007, 9, 1765–1767; (b) Shinada, T.; Ikebe, E.; Oe, K.; Namba, K.; Kawasaki, M.;
Ohfune, Y. Org. Lett. 2010, 12, 2170.
7. (a) Ito, Y.; Matsuura, T.; Saegusa, T. Tetrahedron Lett. 1985, 26, 5781–5784; (b)
Ito, Y.; Sawamura, M.; Hayashi, T. J. Am. Chem. Soc. 1986, 108, 6405–6406; (c)
Togni, A.; Pastor, S. D. Helv. Chim. Acta 1989, 72, 1038–1042.
8. According to the transition state model proposed by Ito–Hayashi et al.,7 the
trans selectivity at C4 and C5 is derived from the enolate geometry to be Z and
the facial selectivity either 5R or 5S is controlled by the chiral catalyst in which
the internal organic base chelates to both the aldol donor and acceptor.
However, the stereochemical outcome of the undesired (4S,5S)-selectivity in
this case remained uncertain due to the structural complexity of the aldol
acceptor 5a which possessed an aldehyde attached to the quaternary carbon
center with the sterically bulky and polar functional groups
In summary, we have developed a short and diastereoselective
route to manzacidin B. The total number of processes from the